CannTrust Releases Q3 Results, Reveals NYSE Listing Plans

Along with the release of its Q3 financial results, CannTrust Holdings (TSX:TRST) announced after market close on Wednesday (November 14), that it is taking steps to become listed on the New York Stock Exchange (NYSE).

The company saw record revenues of C$12.6 million during Q3, indicating a 105 percent increase from Q3 2017’s C$6.14 million revenue. Additionally, CannTrust stated that it is pursuing listing its common shares on the NYSE, but gave few details.

Freshly appointed CEO Peter Aceto commented on the decision, explaining that the listing would be a logical step ahead for the company.

Cannabis Free Report Cover
 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

“CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in science and innovation. A US listing is a natural step forward in our evolution as we look to broaden our investor base and expand our business on an international scale,” he said in the press release.

Highlights from the Q3 report also showed that active patients grew to over 50,000, a 61 percent increase from Q3 2017. These numbers coincide with CannTrust obtaining supply agreements with nine Canadian provinces for recreational cannabis post-legalization.

During Q3, the company also made history with its first shipment of cannabis oil to Denmark, signifying the first and only medical cannabis oil to be accepted into the country.

“We are extremely pleased with our Q3 results that are a testament to the success of this company and the incredible progress that we have made in such a short period of time,” Eric Paul, chairman of the board and former, said in the statement.

“With the opening of the recreational market and the numerous opportunities that our company is positioned to capitalize on, this is only the beginning.”

Paul made headlines in early October when he opted to step down from his CEO position just two weeks before cannabis legalization in Canada. He paved the way for Aceto, formerly the CEO of online bank Tangerine, to fill his place; Paul chose to stay with CannTrust as chairman of the board and by serving as a special advisor to the company’s management team.

Following the announcement, CannTrust shares were way up on Thursday (November 15) boosting 22.85 percent to $8.87 a piece as of 11:00 a.m. EST on the TSX.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

Cannabis Free Report Cover
 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Cease Trade Order Issued by the Ontario Securities Commission

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS/

Avicanna Inc. (the “ Company ” or “ Avicanna ”) (TSX: AVCN) announced today that it has been issued a Cease Trade Order (“ CTO ”) by the Ontario Securities Commission (the “ OSC ”) as it no longer expects to file the following periodic disclosure documents (collectively, the “ Documents ”) by June 11, 2021, as previously disclosed:

Keep reading... Show less

Trulieve Reports Results of 2021 Annual and Special Meeting of Shareholders

Adds two accomplished female directors to the Board

Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the results of its Annual and Special Meeting of Shareholders held on June 10, 2021 (the “Meeting”). Each of the eight individuals nominated for election as a director of Trulieve at the Meeting were elected, including new nominees, Giannella Alvarez and Jane Morreau .

Keep reading... Show less

Cannabis Weekly Round-Up: NFL to Spend US$1 Million on Cannabis Research

The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.

Keep reading... Show less

Trulieve Expands Patient Access with Latest Tampa Dispensary

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a new Florida dispensary, the Company’s 89th nationwide.

The dispensary will be located next to the Citrus Park Town Center and helps meet Trulieve’s goal of ensuring medical cannabis patients across Florida have safe, reliable access to the medications they rely on. The facility joins four other Tampa dispensaries, as well as several more in nearby Clearwater , St. Petersburg , and Largo.

Keep reading... Show less

RCP23 Sells 1,666,667 Subordinate Voting Shares of Green Thumb Industries Inc.

On June 10, 2021, RCP23, LLC (the “Seller”), a private investment holding company controlled by Benjamin Kovler, CEO and Chairman of Green Thumb Industries Inc. (the “Issuer”) (CSE: GTII) (OTCQX: GTBIF), sold 1,666,667 Subordinate Voting Shares of the Issuer (the “Transferred Shares”) to a third-party qualified institutional buyer at a purchase price of US$30.00 per share in a private transaction.

“This transaction brings Green Thumb a new institutional shareholder who is aligned with management’s long-term vision,” said Manager of RCP23 Benjamin Kovler.  “RCP23 has historically sold shares on behalf of our legacy shareholders who invested prior to Green Thumb going public.”

Keep reading... Show less